Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-25-002052)

Filing Details

Accession Number:: 0001104659-25-002052
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-01-08 16:31:33
Reporting Period:: 2025-01-06

Accepted Time:: 2025-01-08 16:31:33
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1736243	Acurx Pharmaceuticals Inc.	ACXP	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1271123	P David Luci	C/O Acurx Pharmaceuticals, Inc., 259 Liberty Avenue Staten Island NY 10305	President And Ceo	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2025-01-06	49,261	$1.02	1,097,458	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrants for Common Stock	Acquisiton	2025-01-06	49,261	$0.00	49,261	$0.90

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
49,261	2025-01-07	2030-01-07	No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	15,083	Indirect	By spouse
Common Stock	35,000	Indirect	By child

Footnotes

Acquired at the offering price in a registered direct offering of common stock by Acurx Pharmaceuticals, Inc.
Acquired in a concurrent private placement of warrants by Acurx Pharmaceuticals, Inc. in connection with the registered direct offering of common stock.